Gardner Lewis Asset Management L P Edwards Lifesciences Corp Transaction History

Gardner Lewis Asset Management L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $2.51 Million - $3.14 Million	-29,965 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $322,246 - $410,078	4,495 Added 17.65%	29,965 $2.73 Million
Q3 2020 Nov 09, 2020	BUY	$67.19 - $87.44 $393,061 - $511,524	5,850 Added 29.82%	25,470 $2.03 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $781,163 - $1.04 Million	13,576 Added 224.62%	19,620 $1.36 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $316,766 - $489,564	6,044 New	6,044 $1.14 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $570,680 - $728,120	-15,345 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $518,507 - $604,439	15,345	15,345 $1.73 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Gardner Lewis Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Gardner Lewis Asset Management L P with notifications on news.